Ani Pharmaceuticals (ANIP) Other Non Operating Income (2011 - 2026)

Ani Pharmaceuticals has disclosed Other Non Operating Income across 16 years of filings, most recently posting -$468000.0 for Q2 2026.

• In Q2 2026, Other Non Operating Income fell 126.91% year-over-year to -$468000.0; the TTM figure through Jun 2026 stood at -$1.1 million (up 79.71% YoY), while the FY2025 annual figure was $1.9 million, up 125.9% from the prior year.
• Other Non Operating Income came in at -$468000.0 for Q2 2026 at Ani Pharmaceuticals, up from -$651000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.7 million in Q2 2025 to a low of -$7.5 million in Q3 2024.
• Average Other Non Operating Income over 5 years is -$368352.9, with a median of -$39000.0 recorded in 2023.
• Year-over-year, Other Non Operating Income sank 19048.72% in 2024 and soared 2076.14% in 2025.
• Over 5 years, Other Non Operating Income stood at -$42000.0 in 2022, then grew by 21.43% to -$33000.0 in 2023, then tumbled by 22530.3% to -$7.5 million in 2024, then surged by 111.38% to $850000.0 in 2025, then sank by 155.06% to -$468000.0 in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$468000.0 in Q2 2026, -$651000.0 in Q1 2026, and $850000.0 in Q4 2025.